Bone Marrow Failure Syndromes Completed Phase 1 / 2 Trials for Nandrolone decanoate (DB08804)

Also known as: Bone Marrow Failure Syndrome / Bone Marrow Failure Disorders

IndicationStatusPhase
DBCOND0035172 (Bone Marrow Failure Syndromes)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02055456Nandrolone Decanoate in the Treatment of TelomeropathiesTreatment